Drug Type Small molecule drug |
Synonyms Alnitak |
Target |
Mechanism TAK1 subfamily inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | CN | 18 Jun 2024 | |
Inflammation | Preclinical | SE | 18 Jun 2024 |